Please click here to obtain permission to reproduce this image.
Click on image to view larger version.
Figure 2 CK-MB Increase in the 2 Treatment Groups
(A) Incidence of creatine kinase myocardial isoenzyme (CK-MB) increase >3x the upper limit of normal (ULN) in the atorvastatin group and in the control group. (B) Incidence of CK-MB increase >3x ULN in the subgroup of patients with normal and high C-reactive protein (CRP) in both the atorvastatin group and in the control group. CI = confidence interval; OR = odds ratio.
|
